1-3 of 3
Silvia Buttignol, MD
Close
Sort by
Journal Articles

Maintenance Therapy With Lenalidomide Significantly Improved Survival Of Yong Newly Diagnosed Multiple Myeloma Patients

Francesca Gay, MD, Federica Cavallo, Tommaso Caravita, MD, Maide Cavalli, Arnon Nagler, MD, MSc, Vittorio Montefusco, MD, Enrico Maria Pogliani, MD, Silvia Buttignol, MD, Elena Zamagni, MD, Carmela Palladino, Magda Marcatti, MD, Pellegrino Musto, MD, Lucio Catalano, Anna Baraldi, MD, Angelo Michele Carella, MD, Anna Maria Cafro, MD, Agostina Siniscalchi, MD, Claudia Crippa, MD, Letizia Maria Vallone, Giovannino Ciccone, Dina Ben Yehuda, Francesco Di Raimondo, MD, Izhar Hardan, MD, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2013) 122 (21): 2089.
https://doi.org/10.1182/blood.V122.21.2089.2089
Published: 2013
Journal Articles

Clinical Factors Predictive Of Myelofibrotic Evolutions In Patients With Essential Thrombocythemia and Polycythemia Vera

Mario Tiribelli, MD, Federico De Marchi, MD, Daniela Barraco, MD, Luciana Marin, MD, Erika Codarin, PhD, Silvia Buttignol, MD, Daniela Damiani, MD, Renato Fanin, MD
Journal: Blood
Blood (2013) 122 (21): 4082.
https://doi.org/10.1182/blood.V122.21.4082.4082
Published: 2013
Journal Articles

Conventionally-Defined and PET/CT-Defined Complete Response (CR) to Novel Agent-Based Induction Therapy and Autologous Stem-Cell Transplantation (ASCT) In Multiple Myeloma (MM): A Prospective Study of Clinical and Prognostic Implications

Elena Zamagni, MD, Cristina Nanni, MD, Francesca Patriarca, MD, Annalisa Pezzi, Statistician, Beatrice Anna Zannetti, MD, Paola Tacchetti, MD, Emanuela Englaro, MD, Giulia Perrone, MD, Silvia Buttignol, MD, Annamaria Brioli, MD, Lucia Pantani, MD, Francesca Carobolante, MD, Michele Baccarani, MD, Stefano Fanti, MD, Michele Cavo, MD
Journal: Blood
Blood (2011) 118 (21): 826.
https://doi.org/10.1182/blood.V118.21.826.826
Published: 2011